CannaPharmaRX, Inc.
CPMD
$0.003
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5,175.97% | 4,278.29% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5,175.97% | 4,278.29% | -- | -- | -- |
| Cost of Revenue | 365.01% | 379.32% | 5,657.32% | 5,620.83% | 3,300.35% |
| Gross Profit | -234.83% | -250.70% | -4,407.16% | -4,447.57% | -3,210.76% |
| SG&A Expenses | -26.40% | -55.13% | -53.39% | -100.42% | -91.40% |
| Depreciation & Amortization | -228.95% | -129.81% | -100.08% | -102.99% | -77.18% |
| Other Operating Expenses | -49.00% | -49.00% | -49.00% | -3.47% | -3.47% |
| Total Operating Expenses | 206.83% | 122.21% | 180.93% | -68.66% | -70.85% |
| Operating Income | -124.07% | -66.48% | -128.87% | 74.83% | 71.32% |
| Income Before Tax | -1,001.72% | 116.92% | -368.56% | 118.41% | 107.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,001.72% | 116.92% | -368.56% | 118.41% | 107.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,001.72% | 116.92% | -368.56% | 118.41% | 107.61% |
| EBIT | -124.07% | -66.48% | -128.87% | 74.83% | 71.32% |
| EBITDA | -205.31% | -97.78% | -183.50% | 79.10% | 79.12% |
| EPS Basic | -37.70% | 108.78% | -477.78% | 85.77% | 80.26% |
| Normalized Basic EPS | 67.88% | 108.99% | -187.88% | 2.58% | 4.07% |
| EPS Diluted | -37.70% | 108.78% | -477.78% | 85.77% | 80.26% |
| Normalized Diluted EPS | 67.88% | 108.99% | -187.88% | 2.58% | 4.07% |
| Average Basic Shares Outstanding | 59.53% | 103.05% | 87.39% | 77.86% | 52.88% |
| Average Diluted Shares Outstanding | 59.53% | 103.05% | 87.39% | 77.86% | 52.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |